SUMMA RX LABORATORIES INC
10QSB, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26
Next: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-QSB
FOR THE QUARTER ENDED JULY 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-QSB FOR THE QUARTER ENDED JULY 31, 1998.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          APR-30-1999
<PERIOD-START>                             MAY-01-1998
<PERIOD-END>                               JUL-31-1998
<CASH>                                         291,526
<SECURITIES>                                         0
<RECEIVABLES>                                  208,657
<ALLOWANCES>                                    74,150
<INVENTORY>                                    183,599
<CURRENT-ASSETS>                               691,854
<PP&E>                                       1,630,303
<DEPRECIATION>                                 510,015
<TOTAL-ASSETS>                               1,816,235
<CURRENT-LIABILITIES>                          510,181
<BONDS>                                        570,000
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                     704,596
<TOTAL-LIABILITY-AND-EQUITY>                 1,816,235
<SALES>                                        730,025
<TOTAL-REVENUES>                               730,025
<CGS>                                          414,700
<TOTAL-COSTS>                                  687,274
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,463
<INCOME-PRETAX>                                 24,288
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             24,288
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    24,288
<EPS-BASIC>                                        .01
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission